½ÃÀ庸°í¼­
»óǰÄÚµå
1534415

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå : ±â¼úº°, °æÀï ±¸µµ, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, µ¿Ç⠺м®, °æÀï ±¸µµ, ¿¹Ãø(2019-2030³â)

Japan HealthTech Market, By Technology; By Component; By Application; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Blueweave Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå ±Ô¸ð´Â CAGR 6.16%·Î ´ëÆø È®´ë, 2030³â¿¡´Â 6¾ï 9,512¸¸ ´Þ·¯ µ¹ÆÄ

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀåÀº µµ½Ã Áö¿ªÀÇ ÀÇ·á ¹× °£º´ ¼ö¿ä Áõ°¡¿Í ÇコÄÉ¾î ºÐ¾ß Àη ºÎÁ·À¸·Î ÀÎÇØ Ȱ±â¸¦ ¶ì°í ÀÖ½À´Ï´Ù.

Àü·« ÄÁ¼³ÆÃ ¹× ½ÃÀå Á¶»ç ±â°üÀÎ BlueWeave ConsultingÀº ÃÖ±Ù Á¶»ç¿¡¼­ 2023³â ÀϺ» ÇコÅ×Å© ½ÃÀå ±Ô¸ð¸¦ 3¾ï 4,648¸¸ ´Þ·¯·Î Ãß»êÇßÀ¸¸ç, 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß ÀϺ» ÇコÅ×Å© ½ÃÀå ±Ô¸ð´Â ½ÃÀå ±Ô¸ð°¡ ¿¬Æò±Õ 6.16% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 9,512¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀϺ»ÀÇ °í·ÉÈ­, ¿þ¾î·¯ºí ¹× ¸ð¹ÙÀÏ Çコ(¸ð¹ÙÀÏ Çコ) ¿ëµµ°ú °°Àº ÇコÄÉ¾î ±â¼úÀÇ µîÀå Áõ°¡´Â ÀϺ» ÇコÅ×Å© ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ Áß ÀϺ»ÀÇ Çコ Å×Å© ½ÃÀåÀº °£º´ ¹× ÀÇ·á ºÐ¾ßÀÇ ½É°¢ÇÑ Àη ºÎÁ·¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±âȸ: ´ç´¢º´ ¹× ±âŸ ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀåÀº ¿ëµµº°·Î ¼øÈ¯±â°ú, ´ç´¢º´°ú, ½Å°æ°ú, ¼ö¸é¹«È£ÈíÁõ°ú, Á¾¾ç°ú, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ´ç´¢º´ ºÐ¾ß´Â ÀϺ»³» ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ±¹¸³º¸°Ç¿ø¿¡ µû¸£¸é ÇöÀç ÀϺ» Àα¸ÀÇ ¾à 13.5%°¡ 2Çü ´ç´¢º´(³»´ç´É ÀÌ»ó)À» ¾Î°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ±â¼úÀº ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛ, ½º¸¶Æ® Àν¶¸° Ææ, ½Ç½Ã°£ °Ç°­ µ¥ÀÌÅÍ, ÁúÀû ÀúÇ÷´ç °æº¸ µîÀ» ÅëÇØ ´ç´¢º´À» ´õ Àß °ü¸®Çϰí ÀÇ·áÁøÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

ÁöÁ¤ÇÐÀû ±äÀåÀÌ °íÁ¶µÇ´Â °ÍÀÌ ÀϺ» ÇコÅ×Å© ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÁöÁ¤ÇÐÀû ±äÀåÀÇ °ÝÈ­´Â ÀϺ» ÇコÅ×Å© ½ÃÀåÀ» È¥¶õ¿¡ ºü¶ß¸± ¼ö ÀÖ½À´Ï´Ù. ÀϺ»°ú À̽º¶ó¿¤Àº À̽º¶ó¿¤ÀÌ Á¦°øÇÏ´Â ±â¼ú ÀÚ»êÀ¸·Î ÀÎÇØ ÇコÅ×Å© ºÐ¾ß¿¡¼­ ±ä¹ÐÇÑ °ü°è¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀϺ»³» À̽º¶ó¿¤ Å»Åð ¿îµ¿ÀÌ µµÀԵǰí ÀÖÀ¸¸ç, ¾ç±¹ °£ ÀáÀçÀû Çù·Â °ü°è¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àη ¹× ÀÚ±Ý ºÎÁ·Àº À̽º¶ó¿¤ÀÇ ±â¼ú ºÎ¹® ¿î¿µÀ» ¹æÇØÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀ¸·Î, ÀÌ´Â ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÃÄ ½ÃÀå È®´ë¸¦ Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå

ºÎ¹®º° Àû¿ë ¹üÀ§

ÀϺ» ÇコÅ×Å© ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

ÃÖÁ¾»ç¿ëÀÚº°·Î º¸¸é ÀϺ» ÇコÄÉ¾î ½ÃÀåÀº ÀÇ·á Á¦°øÀÚ, ÇコÄɾî ÁöºÒÀÚ, ÇコÄÉ¾î ¼ÒºñÀÚ, Á¦¾àȸ»ç, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ÀÇ·á ¼ÒºñÀÚ ºÎ¹®ÀÌ ÀϺ» ÇコÄÉ¾î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ÁÖ·Î ÇコÄÉ¾î ±â±âÀÇ Ãâ½Ã Áõ°¡¿Í ȯÀÚ °ü¸® ¼­ºñ½ºÀÇ °¡¿ë¼º ¹× Á¢±Ù¼º Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÇコÄɾî´Â ¿ø°Ý ¸ð´ÏÅ͸µ, °Ç°­ Á¤º¸ Á¢±Ù µî ÀÇ·á Á¢±Ù¼º Ãø¸é¿¡¼­ ȯÀڵ鿡°Ô ¸¹Àº ÆíÀǸ¦ Á¦°øÇÕ´Ï´Ù. ȯÀÚµéÀº ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ÃßÀûÇϰí ÀÇ·á Àü¹®°¡¿Í ¿ø°ÝÀ¸·Î °øÀ¯ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀÇ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ

ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ÁÖ¿ä ±â¾÷¿¡´Â Allm Inc., M3, Inc., Omron, Whill, FiNC, CureApp, AI Medical Service, Awarefy, and iCARE.°¡ Æ÷ÇԵ˴ϴÙ. ÀÌµé ±â¾÷Àº ½ÃÀå Á¡À¯À²À» ³ôÀ̱â À§ÇØ M&A, ÆÄÆ®³Ê½Ê, ÇÕÀÛÅõÀÚ, ¶óÀ̼±½º °è¾à, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÀϺ» ÇコÅ×Å© ½ÃÀåÀÇ ¼ºÀå ÀáÀç·Â, ÇâÈÄ µ¿Çâ, ±×¸®°í ½ÃÀå Àü¸Á¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ Àüü ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» ÃËÁøÇÏ´Â ¿äÀεµ ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â ÀϺ» ÇコÅ×Å© ½ÃÀåÀÇ Ãֽбâ¼ú µ¿Çâ°ú ¾÷°è ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ÀÇ»ç°áÁ¤ÀÚµéÀÌ ¿Ã¹Ù¸¥ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½°íÀÚ ÇÕ´Ï´Ù. ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µµÀü °úÁ¦, °æÀï·Â¿¡ ´ëÇØ¼­µµ ºÐ¼®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ÇÁ·¹ÀÓ¿öÅ©

Á¦2Àå °³¿ä

Á¦3Àå ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå ÀλçÀÌÆ®

  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • DROC ºÐ¼®
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀϺ»ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­
      • µµ½Ã ÀǷᡤÄÉ¾î ¼ö¿ä Áõ°¡
      • ÀǷᡤÄÉ¾î ºÐ¾ß ÀÎÀç ºÎÁ·
      • COVID-19 ÆÒµ¥¹Í¿¡ ÀÇÇØ µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ °¡¼Ó
    • ¾ïÁ¦¿äÀÎ
      • µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ¹Ì¼÷ÇÑ »óȯ ½Ã½ºÅÛ
      • °í·ÉÀÚ ¼öÀÔÀº ÇÑÁ¤µÇ¾î ÀÖÀ¸¸ç, ¼Ö·ç¼ÇÀ» ¼öÀÍÈ­ ÇÏ´Â °ÍÀº °ï¶õ
      • ¾ð¾î º®. ´ëºÎºÐÀÇ »ç¶÷ÀÌ ¿µ¾î¸¦ ÇÏÁö ¾Ê´Â´Ù.
    • ±âȸ
      • ¿ø°ÝÀÇ·á, ÀüÀÚ Ã³¹æÀü, µðÁöÅÐ Çコ ¾Û »óȯÀÌ È帧À» ¹Ù²Û´Ù.
      • °Ç°­¡¤¿¹¹æÀÇÇÐ ºÐ¾ß´Â »ç¶÷µéÀÌ Àڱ⠺δãÀ» ½È¾îÇÏÁö ¾Ê±â ¶§¹®¿¡ ¸Å·ÂÀûÀÌ´Ù.
      • ÀϺ»ÀÇ »ý¸íº¸Çè ȸ»ç´Â µðÁöÅÐ Çコ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí, M&A¸¦ ½ÃÇàÇϰí ÀÖ´Ù.
      • ¹Ì±¹°úÀÇ ±ÔÁ¦ Á¶È­¿¡ ÀÇÇØ ÀÇ·á±â±â ½ÃÀå Âü¿©°¡ ¿ëÀÌÇÏ°Ô µÈ´Ù.
    • °úÁ¦
      • ±â¼úÀÇ ÃßÁø°ú ȯÀÚ À¯Ä¡ÀÇ ±ÕÇüÀ» ¸ÂÃß°í Áö¿ªÀÇ ¹®Á¦¿Í °¡Ä¡ Á¦¾ÈÀ» ÀÌÇØÇÑ´Ù.
      • ÀϺ» ½ÃÀå¿¡ ÀûÀýÇÑ Çõ½ÅÀûÀÌ°í ¼öÀͼº ³ôÀº ºñÁö´Ï½º ¸ðµ¨ÀÇ °³¹ß
      • À¯Åë, ÇÁ·Î¸ð¼Ç, ½ÃÀå Á¢±ÙÀ» À§ÇÑ ÀûÀýÇÑ ÇöÁö ÆÄÆ®³Ê¸¦ ã¾Æ³½´Ù.
      • ±ÔÁ¦ ½ÂÀÎ ÇÁ·Î¼¼½º¿Í »óȯ Á¦µµ¸¦ ÀÌÇØÇÑ´Ù.
  • ±â¼úÀÇ Áøº¸/ÃÖ±Ù µ¿Çâ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå : ¸¶ÄÉÆÃ Àü·«

Á¦5Àå ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå °³¿ä

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Å×Å©³î·¯Áöº°
      • µðÁöÅÐ Çコ ½Ã½ºÅÛ
      • °Ç°­ ºÐ¼®
      • ÀÇ·á Á¤º¸±â¼ú
      • ¸ð¹ÙÀÏ Çコ(¸ð¹ÙÀÏ Çコ)
      • ¿ø°ÝÀÇ·á
    • ÄÄÆ÷³ÍÆ®º°
      • Çϵå¿þ¾î
      • ¼ÒÇÁÆ®¿þ¾î
      • ¼­ºñ½º
    • ¿ëµµº°
      • ½ÉÀ庴
      • ´ç´¢º´
      • ½Å°æ
      • ¼ö¸é¹«È£Èí
      • Á¾¾ç
      • ±âŸ
    • ÃÖÁ¾»ç¿ëÀÚº°
      • ÇコÄɾî ÇÁ·Î¹ÙÀÌ´õ
      • ÇコÄɾî ÁöºÒÀÚ
      • ÇコÄÉ¾î ¼ÒºñÀÚ
      • Á¦¾àȸ»ç
      • ±âŸ

Á¦6Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷°ú ¹üÀ§ ¸®½ºÆ®
  • ÀϺ»ÀÇ ÇコÅ×Å© ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • °æ¿µ ÆÄ¶ó¹ÌÅÍ¿¡ ÀÇÇÑ °æÀï º¥Ä¡¸¶Å·
  • ÁÖ¿ä Àü·«Àû µµÀÔ(ÇÕº´, Àμö, Á¦ÈÞ)

Á¦7Àå ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÌ ÀϺ»ÀÇ ÇコÅ×Å© ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦8Àå ±â¾÷ °³¿ä(ȸ»ç °³¿ä, À繫 ¸ÅÆ®¸¯½º, °æÀï ±¸µµ, ÁÖ¿äÀι°, ÁÖ¿ä °æÀï, ¿¬¶ôó, Àü·« Àü¸Á, SWOT ºÐ¼®)

  • Allm Inc.
  • M3, Inc.
  • Omron
  • Whill
  • FiNC
  • CureApp
  • AI Medical Service
  • Awarefy
  • iCARE
  • ±âŸ ÁÖ¿ä ±â¾÷

Á¦9Àå ÁÖ¿ä Àü·«Àû Á¦¾È

Á¦10Àå Á¶»ç ¹æ¹ý

KSA 24.08.26

Japan HealthTech Market Size Expands at Significant CAGR of 6.16% to Surpass Value of USD 695.12 Million by 2030

Japan HealthTech Market is flourishing because of an increasing demand for medical and nursing care in urban areas and labor shortage in the healthcare care sector.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Japan HealthTech Market size at USD 346.48 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Japan HealthTech Market size to expand at a CAGR of 6.16% reaching a value of USD 695.12 million by 2030. The country's aging population and the increasing introduction of healthcare technology, such as wearables and mHealth applications, are key drivers of the Japan Healthtech Market. Over the forecast period, Japan Healthtech Market is also expected to be driven by a severe labor shortage in the nursing and medical care sectors.

Opportunity: High Prevalence of diabetes and other chronic diseases

Japan HealthTech Market, based on application, is segmented into cardiology, diabetes, neurology, sleep apnea, oncology, and others. The diabetic segment holds the largest share in the market owing to the high prevalence of the chronic disease in Japan. According to the National Institutes of Health, currently, type 2 diabetes, or impaired glucose tolerance, affects around 13.5% of the population in Japan. Healthtech facilitates better management of diabetes through continuous glucose monitoring (CGM) system, smart insulin pens, real-time health data, qualitative hypoglycemia alarms, and others, which allows healthcare providers to make informed decisions.

Impact of Escalating Geopolitical Tensions on Japan HealthTech Market

The escalating geopolitical tensions may disrupt the Japan Healthtech market. Japan and Israel have close ties in the healthtech sector owing to the technological assets offered by the latter. However, divestment campaigns against Israel are being launched, which might impede potential collaboration between the two nations. Lack of manpower and funding is another factor impeding Israel's technology sector operations, which might have a direct impact on Japan Healthtech Market and may restrict its expansion.

Japan HealthTech Market

Segmental Coverage

Japan HealthTech Market - By End User

Based on end user, Japan HealthTech Market is segmented into healthcare providers, healthcare payers, healthcare consumers, pharmaceutical companies, and others. The healthcare consumers segment dominates Japan Healthtech Market. The growth of the segment is mainly attributed to the increasing launches of healthtech devices and the rising availability and accessibility of patient-care services. Healthtech offers many conveniences to patients in terms of healthcare accessibility, such as remote monitoring and access to health information. Patients can track and share their vitality with their healthcare professionals remotely, which acts as a major driving force for market growth.

Competitive Landscape

Major players operating in Japan HealthTech Market include Allm Inc., M3, Inc., Omron, Whill, FiNC, CureApp, AI Medical Service, Awarefy, and iCARE. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Japan HealthTech Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Japan HealthTech Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Japan HealthTech Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Japan's Rapidly Aging Population
      • 3.2.1.2. Increased Demand for Medical and Nursing Care in Urban Areas
      • 3.2.1.3. Labor Shortage in the Medical and Nursing Care Sectors
      • 3.2.1.4. COVID-19 Pandemic has Accelerated the Need for Digital Health Solutions
    • 3.2.2. Restraints
      • 3.2.2.1. Immature Reimbursement System for Digital Health Solutions
      • 3.2.2.2. Elderly Population has Limited Income, Making it Difficult to Monetize Solutions
      • 3.2.2.3. Language Barrier, as Most People don't Speak English
    • 3.2.3. Opportunities
      • 3.2.3.1. Telemedicine, E-Prescriptions, and Reimbursement for Digital Health Apps will be Game-Changers
      • 3.2.3.2. Wellness and Preventive Medicine Segments are Attractive, as People are Willing to Pay Out-Of-Pocket
      • 3.2.3.3. Japanese Life Insurers are Investing in Digital Health Solutions and Conducting M&A
      • 3.2.3.4. Harmonization of Regulations with the U.S. is Making Market Entry Easier for Medical Devices
    • 3.2.4. Challenges
      • 3.2.4.1. Balancing Tech Push with Patient Pull and Understanding the Local Problem and Value Proposition
      • 3.2.4.2. Developing Innovative, Profitable Business Models suited to the Japanese Market
      • 3.2.4.3. Finding the Right Local Partner for Distribution, Promotion, and Market Access
      • 3.2.4.4. Navigating the Regulatory Approval Process and Reimbursement System
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Japan HealthTech Market: Marketing Strategies

5. Japan HealthTech Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
      • 5.2.1.1. Digital Health Systems
      • 5.2.1.2. Health Analytics
      • 5.2.1.3. Health Information Technology
      • 5.2.1.4. mHealth
      • 5.2.1.5. Telehealthcare
    • 5.2.2. By Component
      • 5.2.2.1. Hardware
      • 5.2.2.2. Software
      • 5.2.2.3. Services
    • 5.2.3. By Application
      • 5.2.3.1. Cardiology
      • 5.2.3.2. Diabetes
      • 5.2.3.3. Neurology
      • 5.2.3.4. Sleep Apnea
      • 5.2.3.5. Oncology
      • 5.2.3.6. Others
    • 5.2.4. By End User
      • 5.2.4.1. Healthcare Providers
      • 5.2.4.2. Healthcare Payers
      • 5.2.4.3. Healthcare Consumers
      • 5.2.4.4. Pharmaceutical Companies
      • 5.2.4.5. Others

6. Competitive Landscape

  • 6.1. List of Key Players and Their Range
  • 6.2. Japan HealthTech Company Market Share Analysis, 2023
  • 6.3. Competitive Benchmarking, By Operating Parameters
  • 6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

7. Impact of Escalating Geopolitical Tensions on Japan HealthTech Market Industry

8. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, and SWOT Analysis)

  • 8.1. Allm Inc.
  • 8.2. M3, Inc.
  • 8.3. Omron
  • 8.4. Whill
  • 8.5. FiNC
  • 8.6. CureApp
  • 8.7. AI Medical Service
  • 8.8. Awarefy
  • 8.9. iCARE
  • 8.10. Other prominent players

9. Key Strategic Recommendations

10. Research Methodology

  • 10.1. Qualitative Research
    • 10.1.1. Primary & Secondary Research
  • 10.2. Quantitative Research
  • 10.3. Market Breakdown & Data Triangulation
    • 10.3.1. Secondary Research
    • 10.3.2. Primary Research
  • 10.4. Breakdown of Primary Research Respondents
  • 10.5. Assumption & Limitation

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦